Clinical trial
Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health
NCT00200824 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00200824 |
|---|---|
| Title | Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health |
| Official title | Effects of Soy Isoflavones on the Prostate, Breast and Bone |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Prostate Cancer |
| Intervention type | Drug |
| Interventions | Soy Isoflavone Nutritional Supplements |
| Start date | May 1, 2000 |
| Completion | Jan 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 12, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: